ACE Technology Guidances communicate recommendations from the MOH Drug Advisory Committee or the MOH Medical Technology Advisory Committee on the funding status and appropriate use of drugs, vaccines or medical technologies that have been evaluated by ACE. The guidances also include the Committee’s rationale for the funding recommendations, and key clinical and economic evidence which informed their deliberations. Plain English Summaries (PES) to explain ACE Technology Guidances are available for patients and the public.

Published on 21 Jun 2023
Last Updated on 21 Jun 2023
A- A+
Guidance Recommendation

The Ministry of Health’s Medical Technology Advisory Committee has not recommended subsidy for presbyopia-correcting intraocular lenses (IOLs) for the treatment of patients with cataract.

Funding status

Presbyopia-correcting IOLs are not recommended for subsidy in patients with the abovementioned indication. 


Presbyopia-correcting intraocular lenses